Windsor Advisory Group’s AbbVie ABBV Stock Holding History

Windsor Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$425K	Buy	1,689 +457	+37%	+$98.3K	0.31%	44
2026 Q1	$268K	Sell	1,232 -103	-8%	-$22.8K	0.22%	45
2025 Q4	$305K	Hold	1,335	–	–	0.27%	43
2025 Q3	$309K	Hold	1,335	–	–	0.27%	49
2025 Q2	$248K	Hold	1,335	–	–	0.35%	35
2025 Q1	$280K	Sell	1,335 -49	-4%	-$9.53K	0.36%	32
2024 Q4	$246K	Sell	1,384 -214	-13%	-$39.3K	0.29%	45
2024 Q3	$316K	Sell	1,598 -42	-3%	-$7.84K	0.36%	46
2024 Q2	$281K	Sell	1,640 -126	-7%	-$20.9K	0.56%	29
2024 Q1	$322K	Buy	1,766 +53	+3%	+$9.13K	0.91%	27
2023 Q4	$265K	Sell	1,713 -139	-8%	-$20.3K	0.79%	33
2023 Q3	$276K	Sell	1,852 -206	-10%	-$30.2K	0.66%	34
2023 Q2	$277K	Hold	2,058	–	–	0.69%	32
2023 Q1	$328K	Sell	2,058 -129	-6%	-$19.7K	0.79%	29
2022 Q4	$353K	Buy	+2,187	New	+$335K	0.94%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Windsor Advisory Group's ABBV Position: Q2 2026 in Review

Windsor Advisory Group increased its AbbVie (ABBV) stake by 37% in Q2 2026, buying an estimated $98.3K and bringing the position to 1,689 shares worth $425K. The position accounts for 0.31% of the portfolio, ranked #44.

Windsor Advisory Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Windsor Advisory Group held 1,689 shares of AbbVie worth $425K as of Q2 2026.
Windsor Advisory Group bought 457 AbbVie shares in Q2 2026, an estimated $98.3K.
AbbVie made up 0.31% of Windsor Advisory Group's portfolio in Q2 2026, its #44 holding.
Windsor Advisory Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Windsor Advisory Group's 13F filing for Q2 2026, filed 14 Aug 2026.